Poland sees surge in GLP-1 drug use, 4.5% of households now using Ozempic

GLP-1 drugs are now used in 4.5% of Polish households, with another 12% considering starting. This rapid adoption, driven by celebrity weight-loss trends, is altering consumer behavior and may strain healthcare resources. The long-term health and economic implications remain uncertain.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works